• Canadian Critical Care Trials Group
    The Canadian Critical Care Trials Group (CCCTG) is a highly collegial group that is dedicated to the pursuit of excellence and advancement of critical care research in Canada.
  • Canadian Critical Care Trials Group
    The CCCTG has are more than 30 research programs underway and over 100 peer-reviewed publications to its credit, with direct impact on clinical practice in critical care.
  • Canadian Critical Care Trials Group
    The Canadian Critical Care Trials Group (CCCTG) is a national organization of more than 300 individuals with research interests in the management of the critically ill patient.
  • Canadian Critical Care Trials Group
    Endorsement by the CCCTG communicates our full commitment to ensure that the work is undertaken in a rigorous and ethical manner, and communicated in a timely and effective way.
Coordinates

Institution

Centre hospitalier de l'Université de Sherbrooke

City

Sherbrooke

Contact This Member

François Lamontagne

Dr. Francois Lamontagne is an intensivist at the Centre Intégré Universitaire de Santé et de Services Sociaux – Estrie in Sherbrooke.

Dr. Francois Lamontagne is an intensivist at the Centre Intégré Universitaire de Santé et de Services Sociaux – Estrie in Sherbrooke, a Clinician Scientist at the Centre de Recherche du CHU de Sherbrooke, and a full Professor of Medicine at the Université de Sherbrooke where he holds an endowed research chair on patient-centred research. He has completed a master’s degree in pharmacology (Université de Sherbrooke) and another in Clinical Epidemiology and Biostatistics (McMaster University). Dr. Lamontagne has created a methodological unit with a view of supporting academic, investigator-initiated clinical research activities. Having established a culture of communication between a multidisciplinary research team and the clinicians and administrators responsible for the delivery of health services, the ‘Unité de Recherche Clinique et Épidémiologique’ is now a highly valued resource province-wide, which continues to grow at a fast rate.

Dr. François Lamontagne’s research activities encompass projects on critical-care therapeutic and diagnostic innovations, but also re-examine standard practices for which the scientific evidence is insufficient. He has personally received peer-reviewed funds from the Canadian Institutes of Health Research, the Fonds de Recherche du Québec - Santé, as well as a not-for-profit private foundation. He is currently leading three multicentre critical care randomized clinical trials. His other activities include numerous knowledge translation projects, such as systematic reviews and guidelines, including collaborations with the World Health Organization.